B cell development: signal transduction by antigen receptors and their surrogates - PubMed (original) (raw)
Review
B cell development: signal transduction by antigen receptors and their surrogates
R J Benschop et al. Curr Opin Immunol. 1999 Apr.
Abstract
Constitutive signal transduction by B cell antigen-receptors and/or their surrogates appears to be critical for progression through multiple developmental checkpoints and for survival of mature B cells in the periphery. Antigen-induced signaling via the B cell receptor can compensate for defects in constitutive signaling and initiates receptor editing, apoptosis and anergy in normal mice - purging the repertoire of autoreactive cells. Thus development and survival of mature B cells seem to require continuous receptor signaling of a defined amplitude.
Similar articles
- Tyrosine kinase activation in the decision between growth, differentiation, and death responses initiated from the B cell antigen receptor.
Hsueh RC, Scheuermann RH. Hsueh RC, et al. Adv Immunol. 2000;75:283-316. doi: 10.1016/s0065-2776(00)75007-3. Adv Immunol. 2000. PMID: 10879287 Review. - The B-cell antigen receptor: formation of signaling complexes and the function of adaptor proteins.
Wienands J. Wienands J. Curr Top Microbiol Immunol. 2000;245(1):53-76. doi: 10.1007/978-3-642-57066-7_2. Curr Top Microbiol Immunol. 2000. PMID: 10533310 Review. No abstract available. - Signal transduction via the B-cell antigen receptor: the role of protein tyrosine kinases and protein tyrosine phosphatases.
Justement LB. Justement LB. Curr Top Microbiol Immunol. 2000;245(1):1-51. doi: 10.1007/978-3-642-57066-7_1. Curr Top Microbiol Immunol. 2000. PMID: 10533309 No abstract available. - Syk tyrosine kinase and B cell antigen receptor (BCR) immunoglobulin-alpha subunit determine BCR-mediated major histocompatibility complex class II-restricted antigen presentation.
Lankar D, Briken V, Adler K, Weiser P, Cassard S, Blank U, Viguier M, Bonnerot C. Lankar D, et al. J Exp Med. 1998 Sep 7;188(5):819-31. doi: 10.1084/jem.188.5.819. J Exp Med. 1998. PMID: 9730884 Free PMC article. - [Regulation of B cell receptor signaling].
Kurosaki T. Kurosaki T. Seikagaku. 2003 Dec;75(12):1505-15. Seikagaku. 2003. PMID: 14748144 Review. Japanese. No abstract available.
Cited by
- Inference of cell state transitions and cell fate plasticity from single-cell with MARGARET.
Pandey K, Zafar H. Pandey K, et al. Nucleic Acids Res. 2022 Aug 26;50(15):e86. doi: 10.1093/nar/gkac412. Nucleic Acids Res. 2022. PMID: 35639499 Free PMC article. - Spatial Stochastic Model of the Pre-B Cell Receptor.
Kerketta R, Erasmus MF, Wilson BS, Halasz AM, Edwards JS. Kerketta R, et al. IEEE/ACM Trans Comput Biol Bioinform. 2023 Jan-Feb;20(1):683-693. doi: 10.1109/TCBB.2022.3166149. Epub 2023 Feb 3. IEEE/ACM Trans Comput Biol Bioinform. 2023. PMID: 35482702 Free PMC article. - Replication timing alterations in leukemia affect clinically relevant chromosome domains.
Rivera-Mulia JC, Sasaki T, Trevilla-Garcia C, Nakamichi N, Knapp DJHF, Hammond CA, Chang BH, Tyner JW, Devidas M, Zimmerman J, Klein KN, Somasundaram V, Druker BJ, Gruber TA, Koren A, Eaves CJ, Gilbert DM. Rivera-Mulia JC, et al. Blood Adv. 2019 Nov 12;3(21):3201-3213. doi: 10.1182/bloodadvances.2019000641. Blood Adv. 2019. PMID: 31698451 Free PMC article. - Characterization of cell fate probabilities in single-cell data with Palantir.
Setty M, Kiseliovas V, Levine J, Gayoso A, Mazutis L, Pe'er D. Setty M, et al. Nat Biotechnol. 2019 Apr;37(4):451-460. doi: 10.1038/s41587-019-0068-4. Epub 2019 Mar 21. Nat Biotechnol. 2019. PMID: 30899105 Free PMC article. - Parsaclisib, a potent and highly selective PI3Kδ inhibitor, in patients with relapsed or refractory B-cell malignancies.
Forero-Torres A, Ramchandren R, Yacoub A, Wertheim MS, Edenfield WJ, Caimi P, Gutierrez M, Akard L, Escobar C, Call J, Persky D, Iyer S, DeMarini DJ, Zhou L, Chen X, Dawkins F, Phillips TJ. Forero-Torres A, et al. Blood. 2019 Apr 18;133(16):1742-1752. doi: 10.1182/blood-2018-08-867499. Epub 2019 Feb 25. Blood. 2019. PMID: 30803990 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous